Millicom International Cellular S.A. Common Stock (TIGO)
Fast GrowerFairStock Score: 78/100 — HIGH CONVICTION
Key Financials
| Current Price | $79.27 |
| Market Cap | $13.9B |
| P/E Ratio | 10.77 |
| ROE | 37.44% |
| Dividend Yield | 3.63% |
| Sector | Communication Services |
Strengths
- Generates $1.4 billion in annual free cash flow (9.9% yield on market cap)
- High return on equity of 37.9% demonstrating efficient capital deployment
- Revenue growth of 15.7% demonstrates strong top-line momentum
- Attractive 3.6% dividend yield providing steady income returns
- FairStock composite score of 78/100 places it in the top tier across value, quality, and momentum factors
Concerns
- High leverage at 2.62x debt-to-equity increases financial risk and interest expense burden
- Altman Z-Score of 1.0 places it in the financial distress zone—elevated bankruptcy risk
AI Analysis
Millicom International Cellular S.A. Common Stock is a mid-cap communication services company valued at $13.9 billion. The business generates $5.8 billion in annual revenue with a 4.3% net margin and $1.4 billion in free cash flow. From a quality standpoint, Millicom shows distressed Altman Z-Score of 1.0 warrants caution and strong 38% ROE. On valuation, the stock is attractively valued at 10.8x earnings, with trades above its Graham Number with a negative 34% margin. Growth dynamics show revenue growing at 15.7% and profit growth of 712.9%. The 3.6% dividend yield adds an income component for patient holders. Our composite FairStock Score of 78/100 reflects strong fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.
Bull Case
Millicom's 16% revenue growth trajectory could accelerate as it captures additional market share in the communication services sector. With $1.4 billion in annual free cash flow (9.9% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.
Bear Case
Elevated leverage at 2.6x D/E means rising interest rates or revenue weakness could strain debt covenants and force asset sales at distressed prices. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer